Drop in mortality seen with AChEI, memantine in dementia with lewy bodies

by Elana GotkineFor patients with dementia with Lewy bodies (DLB), treatment with acetylcholinesterase inhibitors (AChEIs) and/or memantine is associated with reduced hospital admissions and mortality

Updated on: June 24,2024

Drop in mortality seen with AChEI, memantine in dementia with lewy bodies

by Elana GotkineFor patients with dementia with Lewy bodies (DLB), treatment with acetylcholinesterase inhibitors (AChEIs) and/or memantine is associated with reduced hospital admissions and mortality

Updated on:June 24,2024

Opioid analgesics increase the risk of pneumonia among persons with Alzheimer's disease

by University of Eastern FinlandCredit: CC0 Public DomainOpioid analgesics were associated with a 30 percent increase in the risk of pneumonia in persons with Alzheimer's disease, a recent st

Updated on: April 25,2024

Opioid analgesics increase the risk of pneumonia among persons with Alzheimer's disease

by University of Eastern FinlandCredit: CC0 Public DomainOpioid analgesics were associated with a 30 percent increase in the risk of pneumonia in persons with Alzheimer's disease, a recent st

Updated on:April 25,2024

Cognitive performance at age four can be predicted in infancy

by Martin Lasalle,University of MontrealFlorence Deguire’s work opens up the possibility of detecting neurodevelopmental abnormalities that are currently not diagnosed until age four or five. Cr

Updated on: March 28,2024

Cognitive performance at age four can be predicted in infancy

by Martin Lasalle,University of MontrealFlorence Deguire’s work opens up the possibility of detecting neurodevelopmental abnormalities that are currently not diagnosed until age four or five. Cr

Updated on:March 28,2024

Common degenerative brain disease may begin to develop already in middle age

byUniversity of HelsinkiImmunohistochemical staining with 5G4 antibody against alpha-synuclein in the Tampere Sudden Death Study cohort. Black arrowheads highlight LBs and gray arrowheads point

Updated on: March 28,2024

Common degenerative brain disease may begin to develop already in middle age

byUniversity of HelsinkiImmunohistochemical staining with 5G4 antibody against alpha-synuclein in the Tampere Sudden Death Study cohort. Black arrowheads highlight LBs and gray arrowheads point

Updated on:March 28,2024

'Lack of cleaning' in brain cells is central to Alzheimer's disease

by University of CopenhagenCredit: CC0 Public DomainAn international research team with representation from the University of Copenhagen has created a better understanding of Alzheimer's. The

Updated on: May 18,2024

'Lack of cleaning' in brain cells is central to Alzheimer's disease

by University of CopenhagenCredit: CC0 Public DomainAn international research team with representation from the University of Copenhagen has created a better understanding of Alzheimer's. The

Updated on:May 18,2024

Both high and low HDL cholesterol tied to increased risk of dementia

by American Academy of NeurologyCredit: CC0 Public DomainHaving either high or low levels of high-density lipoprotein (HDL) cholesterol, or "good" cholesterol, is tied to a small increa

Updated on: March 02,2024

Both high and low HDL cholesterol tied to increased risk of dementia

by American Academy of NeurologyCredit: CC0 Public DomainHaving either high or low levels of high-density lipoprotein (HDL) cholesterol, or "good" cholesterol, is tied to a small increa

Updated on:March 02,2024

Key gene in familial Alzheimer's disease regulates neuronal development

by Autonomous University of BarcelonaAn international team of researchers led by the Institute of Neuroscience at the Universitat Autònoma de Barcelona describes a new route that promotes differe

Updated on: March 07,2024

Key gene in familial Alzheimer's disease regulates neuronal development

by Autonomous University of BarcelonaAn international team of researchers led by the Institute of Neuroscience at the Universitat Autònoma de Barcelona describes a new route that promotes differe

Updated on:March 07,2024

Rocky start for Alzheimer's drug research in 2018

An Alzheimer sufferer models a creation by designer Guio Di Colombia during the Walkway Inclusion fashion show in Colombia last NovemberThe year 2018, barely underway, has already dealt a series of di

Updated on: March 19,2024

Rocky start for Alzheimer's drug research in 2018

An Alzheimer sufferer models a creation by designer Guio Di Colombia during the Walkway Inclusion fashion show in Colombia last NovemberThe year 2018, barely underway, has already dealt a series of di

Updated on:March 19,2024

Alzheimer's study: Electrostimulation to evoke vivid memories

by Wissam Deeb,The ConversationThe fornix, a tiny part of the brain, may hold some clues to memory loss. Credit: Wissam Deeb, CC BY-SAAlzheimer's diseaseis one of the most dreaded diag

Updated on: April 20,2024

Alzheimer's study: Electrostimulation to evoke vivid memories

by Wissam Deeb,The ConversationThe fornix, a tiny part of the brain, may hold some clues to memory loss. Credit: Wissam Deeb, CC BY-SAAlzheimer's diseaseis one of the most dreaded diag

Updated on:April 20,2024

Older adults with dementia exhibit financial 'symptoms' up to six years before diagnosis

by Johns Hopkins University Bloomberg School of Public HealthCredit: CC0 Public DomainA new study led by researchers at the Johns Hopkins Bloomberg School of Public Health and the Federal Reserve

Updated on: June 11,2024

Older adults with dementia exhibit financial 'symptoms' up to six years before diagnosis

by Johns Hopkins University Bloomberg School of Public HealthCredit: CC0 Public DomainA new study led by researchers at the Johns Hopkins Bloomberg School of Public Health and the Federal Reserve

Updated on:June 11,2024

GluN3A knockout mouse: Alternative model for Alzheimer's neurodegeneration

by Emory UniversityGluN3A (in the diagram, NR3) is an inhibitory subunit within NMDA receptor assemblies, which function as glutamate-gated cation channels. GluN3A is a key regulator of neuronal

Updated on: March 30,2024

GluN3A knockout mouse: Alternative model for Alzheimer's neurodegeneration

by Emory UniversityGluN3A (in the diagram, NR3) is an inhibitory subunit within NMDA receptor assemblies, which function as glutamate-gated cation channels. GluN3A is a key regulator of neuronal

Updated on:March 30,2024

Protein droplets likely don't cause Parkinson's, study suggests

byPaul Scherrer InstituteCredit:Advanced Science(2024). DOI: 10.1002/advs.202308279Liquid-liquid phase separation is not a precursor to formation of amyloid fibrils, a pathological h

Updated on: July 17,2024

Protein droplets likely don't cause Parkinson's, study suggests

byPaul Scherrer InstituteCredit:Advanced Science(2024). DOI: 10.1002/advs.202308279Liquid-liquid phase separation is not a precursor to formation of amyloid fibrils, a pathological h

Updated on:July 17,2024